[HTML][HTML] Pre-clinical investigation of STAT3 pathway in bladder cancer: paving the way for clinical translation

S Mirzaei, MH Gholami, MK Mahabady… - Biomedicine & …, 2021 - Elsevier
Effective cancer therapy requires identification of signaling networks and investigating their
potential role in proliferation and invasion of cancer cells. Among molecular pathways …

Machine learning in prediction of bladder cancer on clinical laboratory data

IJ Tsai, WC Shen, CL Lee, HD Wang, CY Lin - Diagnostics, 2022 - mdpi.com
Bladder cancer has been increasing globally. Urinary cytology is considered a major
screening method for bladder cancer, but it has poor sensitivity. This study aimed to utilize …

[PDF][PDF] Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.

Q Wang, SR Zhu, XP Huang, XQ Liu… - European Review for …, 2021 - europeanreview.org
OBJECTIVE: The systemic immune-inflammation index (SII), an inexpensive and widely
available hematologic marker of inflammation, has been linked to tumor progression …

Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international …

AH Al-Zalabani, A Wesselius, EYW Yu… - Clinical Nutrition, 2022 - Elsevier
Background & aims Tea has been shown to be associated with reduced risk of several
diseases including cardiovascular diseases, stroke, metabolic syndrome, and obesity …

E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies

M Wang, Z Zhang, Z Li, Y Zhu, C Xu - Frontiers in Immunology, 2023 - frontiersin.org
With the rapidly increasing incidence of bladder cancer in China and worldwide, great efforts
have been made to understand the detailed mechanism of bladder cancer tumorigenesis …

The epidemiology of bladder cancer

M Mossanen - Hematology/Oncology Clinics, 2021 - hemonc.theclinics.com
The Epidemiology of Bladder Cancer - Hematology/Oncology Clinics Skip to Main Content Skip
to Main Menu Advertisement Hematology/Oncology Clinics Log in Register Log in Subscribe …

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer

S Bazargan, B Bunch, AME Ojwang '… - Frontiers in …, 2023 - frontiersin.org
Background New therapeutics in development for bladder cancer need to address the
recalcitrant nature of the disease. Intravesical adoptive cell therapy (ACT) with tumor …

Advances in AI‐based cancer cytopathology

Y Yang, S Guan, Z Ou, W Li, L Yan… - Interdisciplinary …, 2023 - Wiley Online Library
Cytopathological examination plays a crucial role in cancer diagnosis as it reflects the
cellular pathology of cancer. However, this process traditionally relies on the visual …

[HTML][HTML] Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways

YR Chen, SC Wang, SP Huang, CC Su, PL Liu… - Biomedicine & …, 2022 - Elsevier
Bladder cancer is one of the most common malignancies of the male genitourinary urinary
system. Protodioscin is a steroidal saponin with anti-cancer effects on several types of …

Her-2 targeted therapy in advanced urothelial cancer: from monoclonal antibodies to antibody-drug conjugates

V Albarrán, DI Rosero, J Chamorro, J Pozas… - International Journal of …, 2022 - mdpi.com
Metastatic urothelial cancer, associated with a poor prognosis, is still major cause of cancer-
related death, with scarce options of effective treatment after progression to platinum-based …